Coloplast takes first place in a new global survey - in front of large international competitors such as Johnson & Johnson and Smith & Nephew - in which more than 400 patient groups around the world evaluated 30 medtech companies' ability to meet patient expectations.
Coloplast generated revenues of DKK 5,707 million and 6% organic growth in the first six months of the financial year 2012/13.
SpeediCath® Compact Set has just been awarded the Red Dot award for its iconic design.
Q1 2012/13 - Interim financial report
Today, the Global 100 Most Sustainable Corporations in the World were announced at the World Economic Forum in Davos. Coloplast moves up from number 84 last year to 67.
Agreement brings Coloplast’s most innovative technologies to more than 2,500 additional hospitals and their patients.
If you continue to browse on this website, you accept the use of cookies.
For more information and how to delete cookies, please read our cookie policy here.